IDRA - Idera Pharmaceuticals GAAP EPS of -$0.08 March, 31 2022 04:39 PM Idera Pharmaceuticals Inc. Idera Pharmaceuticals press release (NASDAQ:IDRA): Q4 GAAP EPS of -$0.08. The company's cash position as of December 31, 2021 was $32.5 million For further details see: Idera Pharmaceuticals GAAP EPS of -$0.08